May 26 2023 This Week in Cardiology
This Week in Cardiology
Medscape Podcasts
4.9 • 963 Ratings
🗓️ 26 May 2023
⏱️ 32 minutes
🔗️ Recording | iTunes | RSS
🧾️ Download transcript
Summary
An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by John Mandrola, MD in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit: https://www.medscape.com/twic
I. HRS Meeting Recap
II. Impella in VT ablation
- First-in-human Experience with Impella 5.0/5.5 for High-Risk Patients with Advanced Heart Failure Undergoing VT Ablationhttps://www.jacc.org/doi/10.1016/j.jacc.2023.05.012
III. Sacubitril/Valsartan
ARNI Bests ARB to Reduce NT-proBNP in Stabilized Preserved-EF HF
https://www.medscape.com/viewarticle/992461
- Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
https://www.jacc.org/doi/10.1016/j.jacc.2023.04.019
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
https://www.nejm.org/doi/full/10.1056/nejmoa1908655
- Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
https://doi.org/10.1093/eurheartj/ehad344
- Bogdan Tweet
https://twitter.com/bogdienache/status/1660356776204595201?s=20
IV. Big Change in Reporting of Medical Evidence – Elan Trial
- Early versus Later Anticoagulation for Stroke with Atrial Fibrillationhttps://www.nejm.org/doi/full/10.1056/NEJMoa2303048
- Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial https://doi.org/10.1177/23969873221106043
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact: news@medscape.net
Transcript
Click on a timestamp to play from that location
| 0:00.0 | You're listening to this week in cardiology from the heart |
| 0:03.4 | org medscape cardiology this podcast is intended for health care |
| 0:07.6 | professionals only any views expressed are the presenters own and do not |
| 0:11.2 | necessarily reflect the views of WebMD or Medscape. |
| 0:15.1 | You can now access the latest in medical news on your Amazon Alexa-enabled device. |
| 0:19.7 | Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I |
| 0:23.7 | highlight the top medical stories of the day. To add Medscape Medical |
| 0:27.4 | Minute to your flash briefing search for Medscape Medical Minute on Amazon |
| 0:31.1 | and click enable or open the Amazon Alexa app go to skills |
| 0:34.7 | search for Medscape Medical Minute and click enable then say Alexa what's the |
| 0:40.1 | news or Alexa what's my flash briefing I hope you'll join us. |
| 0:44.0 | Hi everyone this is John Mandrola from the heart |
| 0:47.3 | org medscape cardiology and this is this week in cardiology for May 26, 2023. |
| 0:55.0 | This week, notes from the Heart Rhythm Society meeting, |
| 0:59.0 | Impella Failure, Saccubitral Valesartan, the purpose of clinical trials, and, and this is big, a major, major breakthrough |
| 1:11.0 | in evidence generation. Now before I say anything about the Heart Rhythm Society |
| 1:16.3 | meeting I want to say thank you to the many listeners that came up to me to say that |
| 1:21.2 | you listen to this week in cardiology. This is no small thing. It means |
| 1:25.8 | a lot to me. Really, really it does. Thank you times 1,000 for stopping to say hello. |
| 1:33.0 | Last week I closed the podcast by saying I'd have some new studies to talk about from |
| 1:38.0 | HRS. Well, the news from HRS is a bit surprising. |
| 1:42.0 | I don't have any major studies to tell you about. The late-breaking |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.